Postes actifs de Charlie Qi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Directeur Technique/Scientifique/R&D | 01/08/2020 | - |
| Roche Global Product Development Center | Corporate Officer/Principal | 01/08/2017 | - |
Historique de carrière de Charlie Qi
Anciens postes connus de Charlie Qi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/05/2012 | 01/08/2017 |
Statistiques
Internationale
| Chine | 3 |
| Îles Cayman | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Roche Global Product Development Center | |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- Charlie Qi
- Expérience
